Assignee profile:

Poxel

City:

Lyons

Country:

France

Published Applications:

11

Last publication date:

2023-04-20

Patent Grants:

11

Last grant date:

2025-05-27

Top Inventors for applications by Poxel

These are the the leading inventors for applications assigned to Poxel:

Recent patent applications by Poxel

Poxel based in Lyons, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-04-20 ✅ Patent 12,310,949 granted on 2025-05-27
US20230120204A1
Human necessities

Use of a thienopyridone derivative in the treatment of autosomal dominant polycystic kidney disease (ADPKD)

#2 | 2023-04-13 ✅ Patent 11,850,238 granted on 2023-12-26
US20230112080A1
Human necessities

Use of a thienopyridone derivative in the treatment of adrenoleukodystrophy or adrenomyeloneuropathy

#3 | 2022-01-20 ✅ Patent 12,319,700 granted on 2025-06-03
US20220017532A1
Chemistry; metallurgy

Monohydrate potassium salt of a thienopyridone derivative and its preparation process

#4 | 2018-06-21 ✅ Patent 10,071,108 granted on 2018-09-11
US20180169115A1
Human necessities

Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection

#5 | 2016-08-04 ✅ Patent 9,895,380 granted on 2018-02-20
US20160220586A1
Human necessities

Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection

#6 | 2015-06-18 ✅ Patent 9,284,329 granted on 2016-03-15
US20150166566A1
Chemistry; metallurgy

Thienopyridone derivatives useful as activators of AMPK

#7 | 2013-12-26 ✅ Patent 8,846,911 granted on 2014-09-30
US20130345421A1
Chemistry; metallurgy

Process of isolating enantiomer components from enantiomer mixtures by particle-size-controlled crystallization

#8 | 2013-10-03 ✅ Patent 8,742,103 granted on 2014-06-03
US20130261300A1
Chemistry; metallurgy

Separation of triazine derivatives enantiomers using tartaric acid

#9 | 2013-02-28 ✅ Patent 9,365,584 granted on 2016-06-14
US20130053401A1
Chemistry; metallurgy

Thieno [2,3-B] pyridinedione activators of AMPK and therapeutic uses thereof

#10 | 2012-05-17 ✅ Patent 8,937,066 granted on 2015-01-20
US20120122873A1
Human necessities

Amino derivatives of dihydro-1,3,5-triazine used in the treatment of ischemia and/or reperfusion related diseases

#11 | 2011-09-29 ✅ Patent 9,035,048 granted on 2015-05-19
US20110236317A1
Chemistry; metallurgy

Tetrahydrotriazine compounds for treating diseases associated with AMPK activity

Also check out POXEL's (Lyons, France) applicant profile with 7 patent applications submitted.

AssigneeID:

479740 ⎘